Scholtz & Company, LLC Paratek Pharmaceuticals, Inc. Transaction History

Scholtz & Company, LLC

  • $207 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$4.58 - $7.14 $74,173 - $115,632
-16,195 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$4.19 - $6.69 $30,587 - $48,837
-7,300 Reduced 31.07%
16,195 $88,000
Q2 2020

Aug 14, 2020
BUY
$2.97 - $5.22 $69,780 - $122,643
23,495 New
23,495 $123,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Scholtz & Company, LLC Portfolio

Follow Scholtz & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scholtz & Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email